Diabetes mellitus after renal transplantation: Characteristics, outcome, and risk factors

Transplantation

Volumn 61, Issue 10, 1996, Pages 1475-1478

  Vesco, Lydia ^a   Busson, Marc ^a   Bedrossian, Janine ^a   Bitker, Marc Olivier ^a   Hiesse, Christian ^a   Lang, Philippe ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HLA SYSTEM; HUMAN; INCIDENCE; INSULIN TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0029898512     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605270-00011     Document Type: Article

References (26)

1. Rao M, Jacob CK, Shastry JCM. Post-renal transplant diabetes mellitus - a retrospective study. Nephrol Dial Transplant 1992; 7: 1039.
2. Paul LC, Sutherland F, Klassen J, Buckle S, Burgess E. Cardiovascular risk impact of cyclosporine immunosuppression in renal transplant recipients. Transplant Proc 1992; 24: 2740.
3. Ahn KJ, Kim YS, Lee HC, Park K, Huh KB. Clinical characteristics and possible risk factors in postrenal transplant diabetes mellitus. Transplant Proc 1992; 24: 1581.
4. Basri N, Aman H, Adiku W, Baraqdar A, Bonatero I, Nezamuddin N. Diabetes mellitus after renal transplantation. Transplant Proc 1992; 24: 1780.
5. Boudreaux JP, McHugh L, Canafax DM, et al. The impact of cyclosporin and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987; 44: 376.
6. Kokot F, Grzeszczak W, Zukowska-Szczechowska E, Wiecek A. Endocrine alterations in kidney transplant patients. Blood Purif 1990; 8: 76.
7. Sumrani NB, Delaney V, Ding Z, et al. Diabetes mellitus after renal transplantation in the cyclosporin era: an analysis of risk factors. Transplantation 1991; 51: 343.
8. Von Kiparski A, Frei D, Uhlschmid G, Largiader F, Binswanger U. Post-transplant diabetes mellitus in renal allograft recipients: a matched-pair control study. Nephrol Dial Transplant 1990; 5: 220.
9. Wood JE, Zincke H, Palumbo PJ. Hyperosmolar nonketotic syndrome and steroid diabetes: occurrence after renal transplantation. JAMA 1975; 231: 1261.
10. Ekstrand A, Erikson JG, Grönhagen-Riska C, Ahonen J, Groop LC. Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 1992; 53: 563.
11. Ruiz JO, Simmons RL, Callender CO, Kjellstrand CM, Busselmeir TJ, Najarian JS. Steroid-induced diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery 1973; 73: 759.
12. Ekstrand A, Ahonen J, Gronhagen-Riska C, Groop L. Mechanisms of insulin resistance after kidney transplantation. Transplantation 1989; 48: 563.
13. Yamamoto H, Akazawa S, Yamaguchi Y, et al. Effects of cyclosporin A and low dosages of steroid on posttransplantation diabetes in kidney transplant recipients. Diabetes care 1991; 14: 867.
14. Friedman AE, Shyh T, Beyer MM, Manis T, But KMH. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985; 5: 196.
15. Irish AB, Simons LA, Savdie E, Hayes JM, Simons J. Metabolic changes in renal transplant patients managed with and without cyclosporin. Clin Transplant 1992; 6: 403.
16. Brinker KR, Dickerman RM, Gonwa TA, et al. A randomized trial comparing double-drug and triple-drug therapy in primary cadaveric renal transplants. Transplantation 1990; 50: 43.
17. Perna AF, Fadda GZ, Zhou XJ, Massry GS. Mechanisms of impaired insulin secretion following chronic excess of parathy-roid hormone. Am J Physiol 1990; 259: 210.
18. Massry GS, Fadda ZG, Zhou XJ, Chandrasoma P, Cheng L, Filburn CR. Impaired insulin secretion of aging: role of renal failure and hyperparathyroidism. Kidney Int 1991; 40: 662.
19. Gunnarson R, Klintmalm G, Lundgren G. Deterioration in glucose metabolism in pancreatic transplant recipients after conversion from azathioprine to cyclosporin. Transplant Proc 1984; 16: 709.
20. Alavi IA, Sharma BK, Pillay VKG. Steroid-induced diabetic ketoacidosis. Am J Med Sci 1971; 262: 15.
21. Gunnarsson R, Arner P, Lundgren G. Steroid diabetes after transplantation: a preliminary report. Scand J Urol Nephrol 1977; 42 (suppl): 191.
22. Garvin PJ, Niehoff M, Staggenborg J. Cyclosporin's effect on canine pancreatic endocrine function. Transplantation 1988; 45: 1027.
23. Hahn HJ, Dunger A, Laube F. Reversibility of acute toxic effect of cyclosporin A on pancreatic B cells of Wistar rats. Diabetologia 1986; 29: 489.
24. Hahn HJ, Laube F, Lucke S, Kloting I, Kohnert KD, Warzock R. Toxic effects of cyclosporin on the endocrine pancreas of Wistar rats. Transplantation 1986; 41: 44.
25. Hricik DE, Bartucci MR, Moir EJ, Mayes JT, Schulak JA. Influence of corticosteroid withdrawal on posttransplant diabetes mellitus in cyclosporin-treated renal transplant recipients. Transplant Proc 1991; 23: 1007.
26. Jindal RM. Posttransplant diabetes mellitus-a review. Transplantation 1994; 58: 1289.